ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.44 USD
-7.11%
Market Closed
Updated:
Apr 26, 2024
ROCE
Return on Capital Employed
Return on Capital Employed
-46.3%
Current
-49%
Average
-30.5%
Industry
ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.
ROCE
=-46.3%
EBIT
/
-166m
Capital Employed
336.9m
ROCE Across Competitors
ROCE Comparison
ADC Therapeutics SA Competitors
ADC Therapeutics SA Competitors
| Country | CH |
| Market Cap | 365.4m USD |
| ROCE |
-46%
|
| Country | US |
| Market Cap | 295.4B USD |
| ROCE |
16%
|
| Country | US |
| Market Cap | 144.2B USD |
| ROCE |
13%
|
| Country | US |
| Market Cap | 102.5B USD |
| ROCE |
22%
|
| Country | US |
| Market Cap | 97.4B USD |
| ROCE |
15%
|
| Country | AU |
| Market Cap | 132B AUD |
| ROCE |
11%
|
| Country | US |
| Market Cap | 81.3B USD |
| ROCE |
18%
|
| Country | US |
| Market Cap | 43.1B USD |
| ROCE |
-27%
|
| Country | US |
| Market Cap | 40.6B USD |
| ROCE |
-23%
|
| Country | US |
| Market Cap | 29.3B USD |
| ROCE |
9%
|
| Country | KR |
| Market Cap | 36.9T KRW |
| ROCE |
6%
|
Profitability Report
View the profitability report to see the full profitability analysis for ADC Therapeutics SA.
See Also
Discover More
What is Return on Capital Employed?
ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.
ROCE
=-46.3%
EBIT
/
-166m
Capital Employed
336.9m
What is the ROCE of ADC Therapeutics SA?
Based on ADC Therapeutics SA's most recent financial statements, the company has ROCE of -46.3%.
You don't have any saved screeners yet
